Internal Medicine, Rheumatology · Corpus Christi, TX
NPI
1982660338
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
4525 S Staples St
Corpus Christi, TX, 78411
Phone (361) 882-7300
Groups this clinician bills Medicare through
Medicare paid, 2024
$423K
40,280 services
Medicare patients, 2024
203
Average age 73
Drug cost, 2024
$9.7M
11,611 prescriptions
Company payments, 2025
$2,732
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ann Aleman Weinmann was code J0897 (injection, denosumab, 1 mg), 4,560 times for 44 patients. In total Ann Aleman Weinmann billed 40,280 services in 33 codes, and Medicare paid $423K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,560 | 44 | $19.81 | $90K |
| 99214 Office E&M - Established | Office | 379 | 187 | $84.60 | $32K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 327 | 156 | $11.54 | $3,772 |
| 96401 Chemotherapy Administration | Office | 153 | 49 | $51.94 | $7,947 |
| 77080 Standard X-ray | Office | 94 | 94 | $35.46 | $3,333 |
| 96413 Chemotherapy Administration | Office | 76 | 12 | $94.93 | $7,214 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 63 | 19 | $0.75 | $47.18 |
| 99204 Office E&M - New | Office | 48 | 48 | $114.38 | $5,490 |
| 99213 Office E&M - Established | Office | 30 | 24 | $64.52 | $1,936 |
| 99442 Telephone Services | Office | 14 | 14 | $42.57 | $596 |
By year: 2022 $496K for 43,081 services; 2023 $468K for 41,037 services; 2024 $423K for 40,280 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ann Aleman Weinmann prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,928 prescriptions and refills. In total Ann Aleman Weinmann wrote 11,611 Medicare prescriptions that cost $9.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,928 | 2,434 | 313 | $36K |
| Methotrexate Methotrexate Sodium | 1,037 | 1,503 | 194 | $8,533 |
| Gabapentin Generic | 713 | 776 | 131 | $8,962 |
| Prednisone Generic | 668 | 833 | 141 | $1,886 |
| Leflunomide Generic | 583 | 807 | 98 | $12K |
| Folic Acid Generic | 563 | 887 | 113 | $2,675 |
| Tramadol Hcl Generic | 544 | 548 | 89 | $6,505 |
| Celecoxib Generic | 488 | 549 | 103 | $5,826 |
| Alendronate Sodium Generic | 435 | 751 | 99 | $1,777 |
| Prolia Denosumab | 292 | 1,746 | 166 | $518K |
| Enbrel Mini Etanercept | 260 | 260 | 31 | $2.2M |
| Sulfasalazine Generic | 250 | 289 | 54 | $3,734 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 241 | 241 | 47 | $4,887 |
| Cyclobenzaprine Hcl Generic | 210 | 232 | 45 | $1,863 |
| Humira(Cf) Pen Adalimumab | 191 | 191 | 22 | $1.4M |
Brand drugs: 2,044 claims; generic drugs: 9,550 claims; opioid claims: 793.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ann Aleman Weinmann $2,732 ($2,732 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $563.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 25 | $563 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $421 |
| Abbvie Inc. ABBV | 13 | $270 |
| Janssen Biotech, Inc. JNJ | 11 | $233 |
| UCB, Inc. UCB.BR | 8 | $226 |
| GlaxoSmithKline, LLC. GSK | 6 | $204 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $195 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $118 |
| Pfizer Inc. PFE | 4 | $94.37 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $85.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.